Life sciences stories
UK clients could see agentic AI projects prototyped in four weeks as Deloitte expands its Google Cloud alliance and trains 1,000 staff.
The advisory body is meant to steer an expanded Cambridge site aiming to house 9,000 people and about 250 life sciences companies by 2028.
Enterprises can now turn plain-language requests into reviewable AI workflows, as Dataiku seeks to close the gap between prototypes and production.
The deal secures rare long-term UK AI capacity as demand for power-hungry inference computing outstrips available data centre infrastructure.
The rack-ready system targets organisations needing denser, liquid-cooled infrastructure as AI and scientific computing demands surge.
The cash will help Cellares build out its European factory network for cell therapies as it eyes commercial-scale operations and a 2027 IPO.
Marketers can now test partner-built AI tools inside LiveRamp, as the limited pilot aims to streamline planning, measurement and activation.
The deal should help the European consultancy expand as demand grows for data analytics and AI advice across financial services and retail.
Closer cooperation in artificial intelligence, health and defence follows Canada-Ireland talks as bilateral trade reached $6 billion last year.
Food and agriculture start-ups may see fresh capital as the firm targets software and biology plays after the sector's sharp funding pullback.
The tie-up aims to help regulated firms move generative AI from pilots into production, while training 50,000 TCS staff on Claude.
Many harmless prompts will now be diverted to Claude Opus 4.8 as Anthropic tightens safeguards around its newest general-use model.
Rising costs, security worries and data sovereignty are pushing more firms to run production AI inferencing in private cloud, a Broadcom survey shows.
Sensitive data can stay off the cloud as Custodia's Sentinel gives executives and researchers a local AI appliance for private document analysis.
It aims to help regulated industries connect AI agents to legacy systems without rebuilding core infrastructure, as demand for production rollouts grows.
Eligible research organisations can now access OpenAI's updated GPT-Rosalind model, as the company widens its life sciences rollout worldwide.
The recognition underlines rising demand for AI-enabled delivery centres as enterprises rethink offshore hubs for product and engineering work.
The move has cut month-end work and lifted invoice processing, while avoiding costly customisation and easing future upgrades.
Greater multiplexing for researchers comes as the new system adds Deep Ultraviolet and Infrared lasers to support 60-colour panel development.
Tighter checks on synthetic DNA orders are gaining traction as AI makes it easier to turn digital designs into real-world biological risks.